Antiviral Drugs Advisory Committee
May 13, 2003 Meeting
Additional Meeting Participants
Acting Industry Representative (non-voting)
Eugene Sun, M.D.
Divisional Vice President, Metabolic and Infectious Diseases Development
Global Pharmaceutical Research & Development
200 Abbott Park Road, Dept. R435, Bldg. LFCP4-4
Abbott Park, Illinois 60064-6229
Joel Morganroth, M.D.
Chief Scientist and Chairman
eResearch Technology, Inc.
30 S. 17th Street
Philadelphia, Pennsylvania 19103
Douglas G. Fish, M.D.
Head, Division of HIV Medicine
Assistant Professor of Medicine
Albany Medical College
47 New Scotland Avenue
Mail Code 158
Albany, New York 12208
D. Roger Illingworth, M.D., Ph.D.
Department of Medicine, L465
Oregon Health & Science University
3181 SW Sam Jackson Park Road
Portland, Oregon 97239
Peter R. Kowey, M.D.
Lankenau Medical Office Building East
100 Lancaster Avenue, West of City Line
Wynnewood, Pennsylvania 19096
Rory P. Remmel, Ph.D.
Department of Medicinal Chemistry
College of Pharmacy
University of Minnesota
7-125C Weaver-Densford Hall
308 Harvard Street S.E.
Minneapolis, Minnesota 55455
Thomas R. Tephly, M.D., Ph.D.
Professor, Department of Pharmacology
College of Medicine
The University of Iowa
Iowa City, Iowa 52242
Ronald G. Washburn, M.D.
Professor of Medicine
Section of Infectious Diseases
Louisiana State University Health Sciences Center
Chief of Infectious Diseases
Overton Brooks VA Medical Center
510 East Stoner Avenue
Shreveport, Louisiana 71101
Patient Representative (voting)
Open Public Hearing Speaker
Antiviral Project Director
Treatment Action Group